                         SEQUENCE LISTING

<110>  Dana-Farber Cancer Institute, Inc.
       Gray, Nathanael S.
       Ferguson, Fleur M.
       Nabet, Behnam
       Buckley, Dennis
 
<120>  SMALL MOLECULE DEGRADERS OF FKBP12 VIA RECRUITMENT OF VON 
       HIPPEL-LINDAU E3 UBIQUITIN LIGASE (VHL) E3 UBIQUITIN LIGASE, AND 
       USES IN dTAG SYSTEMS

<130>  52095-576001WO

<140>  PCT/US20/12348
<141>  2020-01-06

<150>  US 62/789,230
<151>  2019-01-07

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  1

Met Gly Val Gln Val Glu Thr Ile Ser Pro Gly Asp Gly Arg Thr Phe 
1               5                   10                  15      


Pro Lys Arg Gly Gln Thr Cys Val Val His Tyr Thr Gly Met Leu Glu 
            20                  25                  30          


Asp Gly Lys Lys Val Asp Ser Ser Arg Asp Arg Asn Lys Pro Phe Lys 
        35                  40                  45              


Phe Met Leu Gly Lys Gln Glu Val Ile Arg Gly Trp Glu Glu Gly Val 
    50                  55                  60                  


Ala Gln Met Ser Val Gly Gln Arg Ala Lys Leu Thr Ile Ser Pro Asp 
65                  70                  75                  80  


Tyr Ala Tyr Gly Ala Thr Gly His Pro Gly Ile Ile Pro Pro His Ala 
                85                  90                  95      


Thr Leu Val Phe Asp Val Glu Leu Leu Lys Leu Glu 
            100                 105             


<210>  2
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  2
atgggagtgc aggtggaaac catctcccca ggagacgggc gcaccttccc caagcgcggc       60

cagacctgcg tggtgcacta caccgggatg cttgaagatg gaaagaaagt tgattcctcc      120

cgggacagaa acaagccctt taagtttatg ctaggcaagc aggaggtgat ccgaggctgg      180

gaagaagggg ttgcccagat gagtgtgggt cagagagcca aactgactat atctccagat      240

tatgcctatg gtgccactgg gcacccaggc atcatcccac cacatgccac tctcgtcttc      300

gatgtggagc ttctaaaact ggaa                                             324


<210>  3
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  3

Gly Val Gln Val Glu Thr Ile Ser Pro Gly Asp Gly Arg Thr Phe Pro 
1               5                   10                  15      


Lys Arg Gly Gln Thr Cys Val Val His Tyr Thr Gly Met Leu Glu Asp 
            20                  25                  30          


Gly Lys Lys Val Asp Ser Ser Arg Asp Arg Asn Lys Pro Phe Lys Phe 
        35                  40                  45              


Met Leu Gly Lys Gln Glu Val Ile Arg Gly Trp Glu Glu Gly Val Ala 
    50                  55                  60                  


Gln Met Ser Val Gly Gln Arg Ala Lys Leu Thr Ile Ser Pro Asp Tyr 
65                  70                  75                  80  


Ala Tyr Gly Ala Thr Gly His Pro Gly Ile Ile Pro Pro His Ala Thr 
                85                  90                  95      


Leu Val Phe Asp Val Glu Leu Leu Lys Leu Glu 
            100                 105         


<210>  4
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  4
ggagtgcagg tggaaaccat ctccccagga gacgggcgca ccttccccaa gcgcggccag       60

acctgcgtgg tgcactacac cgggatgctt gaagatggaa agaaagttga ttcctcccgg      120

gacagaaaca agccctttaa gtttatgcta ggcaagcagg aggtgatccg aggctgggaa      180

gaaggggttg cccagatgag tgtgggtcag agagccaaac tgactatatc tccagattat      240

gcctatggtg ccactgggca cccaggcatc atcccaccac atgccactct cgtcttcgat      300

gtggagcttc taaaactgga a                                                321


